These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 14722234

  • 1. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
    Harikumar KG, Pinon DI, Wessels WS, Dawson ES, Lybrand TP, Prendergast FG, Miller LJ.
    Mol Pharmacol; 2004 Jan; 65(1):28-35. PubMed ID: 14722234
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling.
    Dong M, Lam PC, Pinon DI, Abagyan R, Miller LJ.
    Biochemistry; 2009 Jun 16; 48(23):5303-12. PubMed ID: 19441839
    [Abstract] [Full Text] [Related]

  • 8. Direct identification of the agonist binding site in the human brain cholecystokininB receptor.
    Anders J, Blüggel M, Meyer HE, Kühne R, ter Laak AM, Kojro E, Fahrenholz F.
    Biochemistry; 1999 May 11; 38(19):6043-55. PubMed ID: 10320330
    [Abstract] [Full Text] [Related]

  • 9. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D.
    Mol Pharmacol; 1994 Apr 11; 45(4):599-607. PubMed ID: 8183238
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin.
    Foucaud M, Archer-Lahlou E, Marco E, Tikhonova IG, Maigret B, Escrieut C, Langer I, Fourmy D.
    Regul Pept; 2008 Jan 10; 145(1-3):17-23. PubMed ID: 17961734
    [Abstract] [Full Text] [Related]

  • 12. Conformational and molecular modeling studies of sulfated cholecystokinin-15.
    Giragossian C, Stone S, Papini AM, Moroder L, Mierke DF.
    Biochem Biophys Res Commun; 2002 May 10; 293(3):1053-9. PubMed ID: 12051766
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Single amino acid substitution of serine82 to asparagine in first intracellular loop of human cholecystokinin (CCK)-B receptor confers full cyclic AMP responses to CCK and gastrin.
    Wu SV, Yang M, Avedian D, Birnbaumer M, Walsh JH.
    Mol Pharmacol; 1999 May 10; 55(5):795-803. PubMed ID: 10220557
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differences in partial agonist action at cholecystokinin receptors of mouse and rat are dependent on parameters extrinsic to receptor structure: molecular cloning, expression and functional characterization of the mouse type A cholecystokinin receptor.
    Ghanekar D, Hadac EM, Holicky EL, Miller LJ.
    J Pharmacol Exp Ther; 1997 Sep 10; 282(3):1206-12. PubMed ID: 9316827
    [Abstract] [Full Text] [Related]

  • 18. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.
    Schmitz F, Pratt DS, Wu MJ, Kolakowski LF, Beinborn M, Kopin AS.
    Mol Pharmacol; 1996 Aug 10; 50(2):436-41. PubMed ID: 8700154
    [Abstract] [Full Text] [Related]

  • 19. Differential spatial approximation between cholecystokinin residue 30 and receptor residues in active and inactive conformations.
    Dong M, Hadac EM, Pinon DI, Miller LJ.
    Mol Pharmacol; 2005 Jun 10; 67(6):1892-900. PubMed ID: 15774770
    [Abstract] [Full Text] [Related]

  • 20. Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy.
    Harikumar KG, Clain J, Pinon DI, Dong M, Miller LJ.
    J Biol Chem; 2005 Jan 14; 280(2):1044-50. PubMed ID: 15520004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.